The Rta/Orf50 transactivator proteins of the gamma-herpesviridae

Current Topics in Microbiology and Immunology

Volumn 312, Issue , 2007, Pages 71-100

  Staudt, M R ^a   Dittmer, D P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYCLOHEXIMIDE; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; PROTEIN SYNTHESIS INHIBITOR; REPLICATION AND TRANSCRIPTION ACTIVATOR PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; VIRUS PROTEIN; IMMEDIATE EARLY PROTEIN; RTA PROTEIN, HUMAN HERPESVIRUS 8;

DNA BINDING; EPSTEIN BARR VIRUS; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HERPES VIRUS; HERPES VIRUS 68; HERPES VIRUS SAIMIRI; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LATENT PERIOD; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RHADINOVIRUS; RHESUS RHADINOVIRUS; ROTAVIRUS; SEQUENCE HOMOLOGY; TRANSACTIVATION; VIRUS GENE; VIRUS INDUCTION; VIRUS REACTIVATION; ANIMAL; CHEMISTRY; GENETICS; IMMEDIATE EARLY GENE; PHYSIOLOGY; VIRUS ACTIVATION;

CERCOPITHECINE HERPESVIRUS 17; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; MURID HERPESVIRUS 4; SAIMIRIINE HERPESVIRUS 2;

ANIMALS; GENES, IMMEDIATE-EARLY; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; PROMOTER REGIONS (GENETICS); RHADINOVIRUS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; VIRAL PROTEINS; VIRUS ACTIVATION;

EID: 34249943220     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-34344-8_3     Document Type: Review

References (138)

1. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA, Gerhengorn MC (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [see comments] [published erratum appears in Nature 1998 Mar 12;392 (6672):210]. Nature 391 (6662):86-9.
2. Ballestas ME, Chatis PA, Kaye KM (1999). Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284 (5414):641-4.
3. Bechtel J, Grundhoff A, Ganem D (2005a). RNAs in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol 79 (16):10138-46.
4. Bechtel JT, Winant RC, Ganem D (2005b). Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol 79 (8):4952-64.
5. Boname JM, Coleman HM, May JS, Stevenson PG (2004). Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant. J Gen Virol 85 (Pt 1):131-5.
6. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O'Leary JJ (1995). Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1 (12):1274-8.
7. Bowser BS, DeWire SM, Damania B (2002). Transcriptional regulation of the K1 gene product of Kaposi's sacroma-associated herpesvirus. J Virol 76 (24):1257-1283
8. Byun H, Gwack Y, Hwang S, Choe J (2002). Kaposi's sarcoma-associated herpesvirus open reading frame (ORF) 50 transactivates K8 and ORF57 promoters via heterogeneous response elements. Mol Cells 14 (2):185-91.
9. Cannon M, Cesarman E, Boshoff C (2006). KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood 107 (1):277-84.
10. Chang H, Gwack Y, Kingston D, Souvlis J, Liang X, Means RE, Cesarman E, Hutt-Fletcher L, Jung JU (2005). Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA J Virol 79 (8):4651-63.
11. Chang J, Renne R, Dittmer D, Ganem D (2000). Inflammatory cytokines and the reactivation of Kaposi's sarcoma- associated herpesvirus lytic replication. Virology 266 (1):17-25.
12. Chang PJ, Miller G (2004). Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein. J Virol 78 (19):10657-73.
13. Chang PJ, Shedd D, Gradoville L, Cho MS, Chen LW, Chang J, Miller G (2002). Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. J Virol 76 (7):3168-78.
14. Chen H, Lee JM, Wang Y, Huang DP, Ambinder RF, Hayward SD (1999). The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. Proc Natl Acad Sci USA 96 (16):9339-44.
15. Chen J, Ueda K, Sakakibara S, Okuno T, Parravicini C, Corbellino M, Yamanishi K (2001). Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc Natl Acad Sci USA 98 (7):4119-24.
16. Chen J, Ueda K, Sakakibara S, Okuno T, Yamanishi K (2000). Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene. J Virol 74 (18):8623-8634.
17. Ciufo DM, Cannon JS, Poole LJ, Wu FY, Murray P, Ambinder RF, Hayward GS (2001). Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol 75 (12):5614-26.
18. Coleman HM, Brierley I, Stevenson PG (2003). An internal ribosome entry site directs translation of the murine gammaherpesvirus 68MK3 open reading frame. J Virol 77 (24):13093-105.
19. Cox MA, Leahy J, Hardwick JM (1990). An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J Virol 64 (1):313-21.
20. Curreli F, Cerimele F, Muralidhar S, Rosenthal LJ, Cesarman E, Friedman-Kien AE, Flore O (2002). Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication. J Virol 76 (10):5208-19.
21. Damania B, Jeong JH, Bowser BS, DeWire SM, Staudt MR, Dittmer DP (2004). Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses. J Virol 78 (10):5491-9.
22. Damania B, Jung JU (2001). Comparative analysis of the transforming mechanisms of Epstein-Barr virus Kaposi's sarcoma-associated herpesvirus, herpesvirus saimiri. Adv Cancer Res 80, 51-82.
23. Deng H, Chu JT, Rettig MB, Martinez-Maza O, Sun R (2002a). Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression. Blood 100 (5):1919-21.
24. Deng H, Song MJ, Chu JT, Sun R (2002b). Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J Virol 76 (16):8252-64.
25. Deng H, Young A, Sun R (2000). Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. J Gen Virol 81 (Pt 12):3043-8.
26. DeWire SM, Damania B (2005). The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation. J Virol 79 (5):3127-38.
27. DeWire SM, McVoy MA, Damania B (2002). Kinetics of expression of rhesus monkey rhadinovirus (RRV) and identification and characterization of a polycistronic transcript encoding the RRV Orf50/Rta RRV R8, and R8.1 genes. J Virol 76 (19):9819-31.
28. Dittmer DP, Gonzalez CM, Vahrson W, DeWire SM, Hines-Boykin R, Damania B (2005). Whole-genome transcription profiling of rhesus monkey rhadinovirus (RRV). J Virol 79 (13):8637-50.
29. Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, Brosch G, Wintersberger E, Seiser C (1999). Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol 19 (8):5504-11.
30. Duan W, Wang S, Liu S, Wood C (2001). Characterization of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF57 promoter. Arch Virol 146 (2):403-13.
31. Ellwood KB, Yen YM, Johnson RC, Carey M (2000). Mechanism for specificity by HMG-1 in enhanceosome assembly. Mol Cell Biol 20 (12):4359-70.
32. Ensser A, Thurau M, Wittmann S, Fickenscher H (2003). The genome of herpesvirus saimiri C488 which is capable of transforming human T cells. Virology 314 (2):471-87.
33. Fakhari FD, Dittmer DP (2002). Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR J Virol 76 (12):6213-23.
34. Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W, Delecluse HJ (2000). The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19 (12):3080-9.
35. Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, Raab-Traub N, Delecluse HJ, Kenney SC (2004). Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96 (22):1691-702.
36. Foreman KE, Friborg J, Jr., Kong WP, Woffendin C, Polverini PJ, Nickoloff BJ, Nabel GJ (1997). Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma [see comments]. N Engl J Med 336 (3):163-71.
37. Gao SJ, Deng JH, Zhou FC (2003). Productive lytic replicationof a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J Virol 77 (18):9738-49.
38. Godfrey A, Anderson J, Papanastasiou A, Takeuchi Y, Boshoff C (2005). Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA Blood 105 (6):2510-8.
39. Goodwin DJ, Walters MS, Smith PG, Thurau M, Fickenscher H, Whitehouse A (2001). Herpesvirus saimiri open reading frame 50 (Rta) protein reactivates the lytic replication cycle in a persistently infected A549 cell line. J Virol 75 (8):4008-4013.
40. Gradoville L, Gerlach J, Grogan E, Shedd D, Nikiforow S, Metroka C, Miller G (2000). Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J Virol 74 (13):6207-6212.
41. Grundhoff A, Ganem D (2004). Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113 (1):124-36.
42. Gwack Y, Baek HJ, Nakamura H, Lee SH, Meisterernst M, Roeder RG, Jung JU (2003a). Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation. Mol Cell Biol 23 (6):2055-67.
43. Gwack Y, Byun H, Hwang S, Lim C, Choe J (2001a). CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50. J Virol 75 (4):1909-17.
44. Gwack Y, Hwang S, Byun H, Lim C, Kim JW, Choi EJ, Choe J (2001b). Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J Virol 75 (13):6245-8.
45. Gwack Y, Hwang S, Lim C, Won YS, Lee CH, Choe J (2002). Kaposi's Sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3. J Biol Chem 277 (8):6438-42.
46. Gwack Y, Nakamura H, Lee SH, Souvlis J, Yustein JT, Gygi S, Kung HJ, Jung JU (2003b). Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Mol Cell Biol 23 (22):8282-94.
47. Hall KT, Stevenson AJ, Goodwin DJ, Gibson PC, Markham AF, Whitehouse A (1999). The activation domain of herpesvirus saimiri R protein interacts with the TATA-binding protein. J Virol 73 (12):9756-7337.
48. Hong GK, Delecluse HJ, Gruffat H, Morrison TE, Feng WH, Sergeant A, Kenney SC (2004). The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1. J Virol 78 (10):4983-92.
49. Jenner RG, Alba MM, Boshoff C, Kellam P (2001). Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75 (2):891-902.
50. Jeong J, Papin J, Dittmer D (2001). Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (Orf74) and LANA (ORF73) promoters. J Virol 75 (4):1798-807
51. Jia Q, Wu TT, Liao HI, Chernishof V, Sun R (2004). Murine gammaherpesvirus 68 open reading frame 31 is required for viral replication. J Virol 78 (12):6610-20.
52. Klass CM, Krug LT, Pozharskaya VP, Offermann MK (2005). The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production. Blood 105 (10):4028-34.
53. Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, Chandran B (2004). Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78 (7):3601-20.
54. Lagunoff M, Bechtel J, Venetsanakos E, Roy A-M, Abbey N, Herndier B, McMahon M, Ganem D (2002). De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J Virol 76 (5):2440-2448.
55. Lan K, Kuppers DA, Robertson ES (2005). Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jκ, the major downstream effector of the Notch signaling pathway. J Virol 79 (6):3468-78.
56. Lan K, Kuppers DA, Verma SC, Robertson ES (2004). Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J Virol 78 (12):6585-94.
57. Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES (2005). Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J Virol 79 (12):7453-65.
58. Lau LF, Nathans D (1985). Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J 4 (12):3145-51.
59. Lau LF, Nathans D (1987). Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 84 (5):1182-6.
60. Lembo D, Cavallo R, Cornaglia M, Mondo A, Hertel L, Angeretti A, Landolfo S (1999). Overexpression of cellular dihydrofolate reductase abolishes the anti-cytomegaloviral activity of methotrexate. Arch Virol 144 (7):1397-403.
61. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D (2002). The lytic switch protein of KSHVactivates gene expression via functional interaction with RBP-Jκ (CSL), the target of the Notch signaling pathway. Genes Dev 16 (15):1977-89.
62. Liang Y, Ganem D (2003). Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc Natl Acad Sci USA 100 (14):8490-5.
63. Liang Y, Ganem D (2004). RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA J Virol 78 (13):6818-26.
64. Liao W, Tang Y, Kuo YL, Liu BY, Xu CJ, Giam CZ (2003a). Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs. J Virol 77 (17):9399-411.
65. Liao W, Tang Y, Lin SF, Kung HJ, Giam CZ (2003b). K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation. J Virol 77 (6):3809-15.
66. Lin SF, Robinson DR, Oh J, Jung JU, Luciw PA, Kung HJ (2002). Identification of the bZIP and Rta homologues in the genome of rhesus monkey rhadinovirus. Virology 298 (2):181-8.
67. Liu S, Pavlova IV, Virgin HWt., and Speck SH (2000). Characterization of gammaherpesvirus 68 gene 50 transcription. J Virol 74 (4):2029-37.
68. Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, Lieberman PM (2003). Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J Virol 77 (21):11425-35.
69. Lukac DM, Garibyan L, Kirshner JR, Palmeri D, Ganem D (2001). DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J Virol 75 (15):6786-99.
70. Lukac DM, Kirshner JR, Ganem D (1999). Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73 (11):9348-61.
71. Lukac DM, Renne R, Kirshner JR, Ganem D (1998). Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252 (2):304-12.
72. Martinez-Guzman D, Rickabaugh T, Wu TT, Brown H, Cole S, Song MJ, Tong L, Sun R (2003). Transcription program of murine gammaherpesvirus 68. J Virol 77 (19):10488-503.
73. Matsumura S, Fujita Y, Gomez E, Tanese N, Wilson AC (2005). Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J Virol 79 (13):8493-505.
74. May JS, Coleman HM, Smillie B, Efstathiou S, Stevenson PG (2004). Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J Gen Virol 85 (Pt 1):137-46.
75. McAllister SC, Hansen SG, Messaoudi I, Nikolich-Zugich J, Moses AV (2005). Increased efficiency of phorbol ester-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus during S phase. J Virol 79 (4):2626-30.
76. McKnight JL, Pellett PE, Jenkins FJ, Roizman B (1987). Characterization and nucleotide sequence of two herpes simplex virus 1 genes whose products modulate alphatrans-inducing factor-dependent activationof alphagenes. J Virol 61 (4):992-1001.
77. Mitsouras K, Wong B, Arayata C, Johnson RC, Carey M (2002). The DNA architectural protein HMGB1 displays two distinct modes of action that promote enhanceosome assembly. Mol Cell Biol 22 (12):4390-401.
78. Moses AV, Fish KN, Ruhl R, Smith PP, Strussenberg JG, Zhu L, Chandran B, Nelson JA (1999). Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol 73 (8):6892-902.
79. Mumm JS, Kopan R (2000). Notch signaling: from the outside in. Dev Biol 228 (2):151-65.
80. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU (2003). Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77 (7):4205-20.
81. O'Connor C, M, Kedes DH (2006). Mass spectrometric analyses of purified rhesus monkey rhadinovirus reveal 33 virion-associated proteins. J Virol 80 (3):1574-83.
82. Paulose-Murphy M, Ha N-K, Xiang C, Chen Y, Gillim L, Yarchoan R, Meltzer P, Bittner M, Trent J, Zeichner S (2001). Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J Virol 75 (10):4843-4853.
83. Pavlova I, Lin CY, Speck SH (2005). Murine gammaherpesvirus 68 Rta-dependent activation of the gene 57 promoter. Virology 333 (1):169-79.
84. Pavlova IV, Virgin HWt., and Speck SH (2003). Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication. J Virol 77 (10):5731-9.
85. Polson AG, Wang D, DeRisi J, Ganem D (2002). Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. Cancer Res 62 (15):4525-30.
86. Pozharskaya VP, Weakland LL, Offermann MK (2004). Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells. J Gen Virol 85 (Pt 10):2779-87.
87. Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC (1993). Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter BMRF1. Nucleic Acids Res 21 (14):1999-2007.
88. Ragoczy T, Heston L, Miller G (1998). The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol 72 (10):7978-84.
89. Ragoczy T, Miller G (1999). Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes. J Virol 73 (12):9858-66.
90. Ragoczy T, Miller G (2001). Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J Virol 75 (11):5240-51.
91. Renne R, Blackbourn D, Whitby D, Levy J, Ganem D (1998). Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 72 (6):5182-8.
92. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D (1996). Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2 (3):342-6.
93. Rickabaugh TM, Brown HJ, Wu TT, Song MJ, Hwang S, Deng H, Mitsouras K, Sun R (2005). Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 RTA reactivates murine gammaherpesvirus 68 from latency. J Virol 79 (5):3217-22.
94. Rochford R, Lutzke ML, Alfinito RS, Clavo A, Cardin RD (2001). Kinetics of murine gammaherpesvirus 68 gene expression following infection of murine cells in culture and in mice. J Virol 75 (11):4955-63.
95. Roizman B (1996). Herpesviridae. In "Virology" (BNFields DMKnipe, and PMHowley Eds.), Vol. 2, pp. 2221-2230. 2 vols. Lippincott-Raven Philadelphia.
96. Russo James J, Bohenzky Roy A, Chien M-C, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman Isidore S, Chang Y, Moore Patrick S (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93 (25):14862-14867.
97. Sakakibara S, Ueda K, Chen J, Okuno T, Yamanishi K (2001). Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression. J Virol 75 (15):6894-900.
98. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS (1998). Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72 (2):1005-12.
99. Saveliev A, Zhu F, Yuan Y (2002). Transcription mapping and expression patterns of genes in the major immediate-early region of Kaposi's sarcoma-associated herpesvirus. Virology 299 (2):301-14.
100. Schafer A, Lengenfelder D, Grillhosl C, Wieser C, Fleckenstein B, Ensser A (2003). The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication. J Virol 77 (10):5911-25.
101. Seaman WT, Quinlivan EB (2003). Lytic switch protein (ORF50) response element in the Kaposi's sarcoma-associated herpesvirus K8 promoter is located within but does not require a palindromic structure. Virology 310 (1):72-84.
102. Shanley JD, Debs RJ (1989). The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomegalovirus in vitro. Antiviral Res 11 (2):99-106.
103. Shaw RN, Arbiser JL, Offermann MK (2000). Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells. AIDS 14 (7):899-902.
104. Song MJ, Deng H, Sun R (2003). Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 77 (17):9451-62.
105. Song MJ, Hwang S, Wong W, Round J, Martinez-Guzman D, Turpaz Y, Liang J, Wong B, Johnson RC, Carey M, Sun R (2004). The DNA architectural protein HMGB1 facilitates RTA-mediated viral gene expression in gamma-2 herpesviruses. J Virol 78 (23):12940-50.
106. Song MJ, Li X, Brown HJ, Sun R (2002). Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 76 (10):5000-13.
107. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G (1998). A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 95 (18):10866-71.
108. Sun R, Lin SF, Staskus K, Gradoville L, Grogan E, Haase A, Miller G (1999). Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 73 (3):2232-42.
109. Swenson JJ, Holley-Guthrie E, Kenney SC (2001). Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation. J Virol 75 (13):6228-34.
110. Tang S, Zheng ZM (2002). Kaposi's sarcoma-associated herpesvirus K8 exon 3 contains three 5′-splice sites and harbors a K8.1 transcription start site. J Biol Chem 277 (17):14547-56.
111. Thurau M, Whitehouse A, Wittmann S, Meredith D, Fickenscher H (2000). Distinct transcriptional and functional properties of the R transactivator gene Orf50 of the transforming herpesvirus saimiri strain C488. Virology 268 (1):167-77.
112. Triezenberg SJ, LaMarco KL, McKnight SL (1988). Evidence of DNA: protein interactions that mediate HSV-1 immediate early gene activation by VP16. Genes Dev 2 (6):730-42.
113. Trus BL, Heymann JB, Nealon K, Cheng N, Newcomb WW, Brown JC, Kedes DH, Steven AC (2001). Capsid structure of Kaposi's sarcoma-associated herpesvirus, a gammaherpesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirus. J Virol 75 (6):2879-90.
114. Ueda K, Ishikawa K, Nishimura K, Sakakibara S, Do E, Yamanishi K (2002). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gen through two distinct cis elements by a non-DNA-binding mechanism. J Virol 76 (23):12044-54.
115. Walters MS, Hall KT, Whitehouse A (2004). The herpesvirus saimiri open reading frame (ORF) 50 (Rta) protein contains an AT hook required for binding to the ORF 50 response element in delayed-early promoters. J Virol 78 (9):4936-42.
116. Walters MS, Hall KT, Whitehouse A (2005). The herpesvirus saimiri Rta gene autostimulates via binding to a non-consensus response element. J Gen Virol 86 (Pt 3):581-7.
117. Wang J, Zhang J, Zhang L, Harrington W, Jr., West JT, Wood C (2005). Modulation of human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus replication and transcription activator transactivation by interferon regulatory factor 7. J Virol 79 (4):2420-31.
118. Wang S, Liu S, Wu MH, Geng Y, Wood C (2001). Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation. J Virol 75 (24):11961-73.
119. Wang SE, Wu FY, Chen H, Shamay M, Zheng Q, Hayward GS (2004a). Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J Virol 78 (8):4248-67.
120. Wang SE, Wu FY, Fujimuro M, Zong J, Hayward SD, Hayward GS (2003a). Role of CCAAT/enhancer-binding protein α (C/EBPα) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication- associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP J Virol 77 (1):600-23.
121. Wang SE, Wu FY, Yu Y, Hayward GS (2003b). CCAAT/enhancer-binding protein-α is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, PAN promoters. J Virol 77 (17):9590-612.
122. Wang Y, Chong OT, Yuan Y (2004). Differential regulation of K8 gene expression in immediate-early and delayed-early stages of Kaposi's sarcoma-associated herpesvirus. Virology 325 (1):149-63.
123. Wang Y, Li H, Chan MY, Zhu FX, Lukac DM, Yuan Y (2004b). Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J Virol 78 (16):8615-29.
124. Whitehouse A, Carr IM, Griffiths JC, Meredith DM (1997). The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases. J Virol 71 (3):2550-4.
125. Wu TT, Tong L, Rickabaugh T, Speck S, Sun R (2001). Function of Rta is essential for lytic replication of murine gammaherpesvirus 68. J Virol 75 (19):9262-73.
126. Wu TT, Usherwood EJ, Stewart JP, Nash AA, Sun R (2000). Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol 74 (8):3659-67.
127. Xu Y, AuCoin DP, Huete AR, Cei SA, Hanson LJ, Pari GS (2005). A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J Virol 79 (6):3479-87.
128. Ye J, Shedd D, Miller G (2005). An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate. J Virol 79 (3):1397-408.
129. Yu Y, Wang SE, Hayward GS (2005). The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22 (1):59-70.
130. Zalani S, Holley-Guthrie E, Kenney S (1996). Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci USA 93 (17):9194-9.
131. Zhang L, Chiu J, Lin JC (1998). Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent. DNA Cell Biol 17 (9):735-42.
132. Zhong W, Wang H, Herndier B, Ganem D (1996). Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 93 (13):6641-6.
133. Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, Hettler E, Gao SJ (2002). Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 76 (12):6185-96.
134. Zhu FX, Chong JM, Wu L, Yuan Y (2005). Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol 79 (2):800-11.
135. Zhu FX, Cusano T, Yuan Y (1999). Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol 73 (7):5556-67.
136. Zhu FX, Yuan Y (2003). The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with purified virions. J Virol 77 (7):4221-30.
137. Zhu J, Trang P, Kim K, Zhou T, Deng H, Liu F (2004). Effective inhibition of Rta expression and lytic replication of Kaposi's sarcoma-associated herpesvirus by human RNase P. Proc Natl Acad Sci USA 101 (24):9073-8.
138. Zoeteweij JP, Eyes ST, Orenstein JM, Kawamura T, Wu L, Chandran B, Forghani B, Blauvelt A (1999). Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents. J Virol 73 (7):5894-902.